Volume 6 Issue 3
Jul.  2026
Turn off MathJax
Article Contents
Tingting Zhang, Zheng Zhang, Zhechao An, Shoulin Yin, Jianyong Tang, Wei Wu, Xiaojuan Wang, Wenhui Xu, Ying Su, Yingzhe Liu, Shuqin Duan, Jingwei Liu, Fengda Li, Ziyun Zhong, Yanan Liu, Liangliang Li, Yuan Li, Lei Yang, Yunhe Liu, Baofeng Yang, Fan Yang. Acute and subchronic toxicological evaluation of Ganoderma lucidum spore powder in mice[J]. Frigid Zone Medicine, 2026, 6(3): 138-149. doi: 10.1515/fzm-2026-0015
Citation: Tingting Zhang, Zheng Zhang, Zhechao An, Shoulin Yin, Jianyong Tang, Wei Wu, Xiaojuan Wang, Wenhui Xu, Ying Su, Yingzhe Liu, Shuqin Duan, Jingwei Liu, Fengda Li, Ziyun Zhong, Yanan Liu, Liangliang Li, Yuan Li, Lei Yang, Yunhe Liu, Baofeng Yang, Fan Yang. Acute and subchronic toxicological evaluation of Ganoderma lucidum spore powder in mice[J]. Frigid Zone Medicine, 2026, 6(3): 138-149. doi: 10.1515/fzm-2026-0015

Acute and subchronic toxicological evaluation of Ganoderma lucidum spore powder in mice

doi: 10.1515/fzm-2026-0015
Funds:

the Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0537900

the National Multidisciplinary Innovation Team Project in Traditional Chinese Medicine ZYYCX-TD-D-202407

the National Key Research and Development Program of China 2023YFF1204600

the Integration Project of the National Natural Science Foundation of China Joint Fund for Regional Innovation and Development U23A6008

the National Natural Science Fund of China 82473925

the National Natural Science Fund of China 81800784

the National Natural Science Fund of China 82330011

the National Natural Science Fund of China 82472477

the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology 2019QNRC001

the China Postdoctoral Science Foundation 2024M750697

the Key Research and Development Program of Heilongjiang Province GA21C006

the Key Research and Development Program of Heilongjiang Province GA23C002

More Information
  •   Objective  Ganoderma lucidum spore powder (GLSP) consists of small, ovoid reproductive cells released during the later stage of Ganoderma lucidum (G. lucidum) development. Its bioactive constituents are enclosed within a resistant outer wall and become more bioavailable following wall disruption. Although GLSP is widely recognized for its medicinal potential, its safety profile has not been systematically characterized. This study evaluated the acute and subchronic toxicity of GLSP derived from G. lucidum cultivated in Northeast China.  Methods  Acute toxicity was assessed in male and female mice following a single oral administration of GLSP at the maximum feasible dose of 16 g/kg. For the subchronic toxicity study, mice were randomly assigned, with equal numbers of males and females, to a control group (CTL) or to low-, medium-, and high-dose GLSP groups receiving 1.075, 2.15, and 4.3 g/kg/day, respectively. GLSP was administered by oral gavage for 13 consecutive weeks, followed by a 4-week recovery period. Clinical condition, behavior, body weight, and food consumption were monitored throughout the study. Cardiac function was evaluated using electrocardiography and echocardiography, and blood pressure was measured noninvasively. Anti-fatigue and hypoxia-tolerance capacities were evaluated using forced-swimming and hypoxia tolerance tests. Bone mass and microarchitecture were assessed by micro-computed tomography (microCT). At the end of the dosing and recovery periods, serum biochemical parameters, relative organ weights, and histopathological findings were comprehensively evaluated.  Results  In the acute toxicity study, no mortality or abnormal behavior, or other signs of toxicity were observed during the 14-day observation period following a single oral dose of GLSP at 16 g/kg. In the subchronic toxicity study, daily GLSP administration for 13 weeks produced no treatment-related changes in clinical appearance, behavior, body weight, food consumption, serum biochemical parameters, relative organ weights, or histopathological findings at any tested dose. Cardiac function, blood pressure, anti-fatigue capacity, and hypoxia tolerance were not adversely affected. GLSP administration also had no significant effect on bone mass or microarchitecture. Findings after the 4-week recovery period were consistent with those observed at the end of the dosing period.  Conclusions  GLSP produced no observable acute or subchronic toxicity in mice under the conditions of this study. The no-observed-adverse-effect level was therefore considered to be at least 4.3 g/kg/day following 13 weeks of repeated oral administration. These findings support a favorable preclinical safety profile for the further development and application of GLSP.

     

  • loading
  • [1]
    Xu J, Li P. Researches and application of ganoderma spores powder[J]. Adv Exp Med Biol, 2019; 1181: 157-186.
    [2]
    Qi Y, Zhong S, Pan F, et al. Effects of different wall-breaking methods on the nutrient release of Ganoderma lucidum spore powder during in vitro digestion[J]. J Sci Food Agric, 2024; 104(11): 6657-6666. doi: 10.1002/jsfa.13490
    [3]
    Wang J, Ke R, Zhang S. Breaking the sporoderm of Ganoderma lucidum spores by combining chemical reaction with physical actuation[J]. Nat Prod Res, 2017; 31(20): 2428-2434. doi: 10.1080/14786419.2017.1312394
    [4]
    Shi Y J, Zheng H X, Hong Z P, et al. Antitumor effects of different Ganoderma lucidum spore powder in cell- and zebrafish-based bioassays[J]. J Integr Med, 2021; 19(2): 177-184. doi: 10.1016/j.joim.2021.01.004
    [5]
    Chen D, Zhang G, Yang J, et al. Comparative pharmacokinetic analysis of sporoderm-broken and sporoderm-removed Ganoderma lucidum spore in rat by using a sensitive plasma UPLC-QqQ-MS method[J]. Biomed Chromatogr, 2024; 38(2): e5787. doi: 10.1002/bmc.5787
    [6]
    Plosca M P, Chiș M S, Fărcaș A C, et al. Ganoderma lucidum-from ancient remedies to modern applications: Chemistry, benefits, and safety[J]. Antioxidants (Basel), 2025; 14(5): 513. doi: 10.3390/antiox14050513
    [7]
    Zheng W, Lan S, Zhang W, et al. Polysaccharide structure evaluation of Ganoderma lucidum from different regions in China based on an innovative extraction strategy[J]. Carbohydr Polym, 2024; 335: 122079. doi: 10.1016/j.carbpol.2024.122079
    [8]
    Tian J, Wei J, Liu Y, et al. Application of Electronic tongue and HPLC in rapid determination of functional triterpenes and origins of Ganoderma lucidum. Front Nutr, 2024; 11: 1446956. doi: 10.3389/fnut.2024.1446956
    [9]
    Li W, Zhou Q, Lv B, et al. Ganoderma lucidum polysaccharide supplementation significantly activates T-cell-mediated antitumor immunity and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer. J Agric Food Chem, 2024; 72(21): 12072-12082. doi: 10.1021/acs.jafc.3c08385
    [10]
    Chen C, Chen J, Wang Y, et al. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling. Phytomedicine, 2023; 110: 154626. doi: 10.1016/j.phymed.2022.154626
    [11]
    Zhao Y, Li Q, Wang M, et al. Structural characterization of polysaccharides after fermentation from Ganoderma lucidum and its antioxidant activity in HepG2 cells induced by H(2)O(2). Food Chem, 2023; 18: 100682.
    [12]
    Fang L, Zhao Q, Guo C, et al. Removing the sporoderm from the sporoderm-broken spores of Ganoderma lucidum improves the anticancer and immune-regulatory activity of the water-soluble polysaccharide. Front Nutr, 2022; 9: 1006127. doi: 10.3389/fnut.2022.1006127
    [13]
    Shevelev O B, Seryapina A A, Zavjalov E L, et al. Hypotensive and neurometabolic effects of intragastric Reishi (Ganoderma lucidum) administration in hypertensive ISIAH rat strain. Phytomedicine, 2018; 41: 1-6.
    [14]
    Wen L, Sheng Z, Wang J, et al. Structure of water-soluble polysaccharides in spore of Ganoderma lucidum and their antiinflammatory activity. Food Chem, 2022; 373(Pt A): 131374.
    [15]
    Guo C, Guo D, Fang L, et al. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydr Polym, 2021; 267: 118231. doi: 10.1016/j.carbpol.2021.118231
    [16]
    Guo D A, Wei W, Yao C, et al. Chinese herbal medicines with beneficial effects. Frigid Zone Medicine, 2021; 1(2): 79-83. doi: 10.2478/fzm-2021-0010
    [17]
    Yu Z M, Lyu P, Wang L M, et al. Analysis on current situation and development potential of ecological compound plantingof Chinese medicinal materials in Northeast China. Journal of Chinese Medicinal Materials, 2024; 47(5): 1071-1078.
    [18]
    Liu H, Wang J, Sun X, et al. The driving mechanism of soil organic carbon biodegradability in the black soil region of Northeast China. Sci Total Environ, 2023; 884: 163835. doi: 10.1016/j.scitotenv.2023.163835
    [19]
    Xia L, Sun R, Zhang L, et al. A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats. Food Chem Toxicol, 2023; 182: 114175. doi: 10.1016/j.fct.2023.114175
    [20]
    Ren S, Liu H, Sang Q, et al. A review of bioactive components and pharmacological effects of Ganoderma lucidum. Food Sci Nutr, 2025; 13(7): e70623. doi: 10.1002/fsn3.70623
    [21]
    Lin Z. Ganoderma (Lingzhi) in traditional Chinese medicine and Chinese culture. Adv Exp Med Biol, 2019; 1181: 1-13.
    [22]
    Wu T T, Chen Y Y, Yuan Z C, et al. Synergy of de-walled Ganoderma lucidum spore powder (GLSP) on targeted therapy in advanced non-squamous non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutant: Protocol for a randomized, double-blind, placebo-controlled study. BMC Complement Med Ther, 2024; 24(1): 125. doi: 10.1186/s12906-024-04416-2
    [23]
    Chen X, Liu X, Sheng D, et al. Distinction of broken cellular wall Ganoderma lucidum spores and G. lucidum spores using FTIR microspectroscopy[J]. Spectrochim Acta A Mol Biomol Spectrosc, 2012; 97: 667-672. doi: 10.1016/j.saa.2012.07.046
    [24]
    Thuy N H L, Tu V L, Thu L N A, et al. Pharmacological activities and safety of Ganoderma lucidum spores: A systematic review. Cureus, 2023; 15(9): e44574.
    [25]
    Zhang M, Wu M Y, Yang L F, et al. Quality analysis of broken Ganoderma lucidum spores produced from different origin raw materials. China Fruit & Vegetable, 2019; 39(3): 7-13.
    [26]
    He X, Chen Y, Li Z, et al. Germplasm resources and secondary metabolism regulation in Reishi mushroom (Ganoderma lucidum). Chin Herb Med, 2023; 15(3): 376-382.
    [27]
    Wang J H, Wang Y F, Shi L, et al. Comparative study on cultivation adaptability in cold regions of 20 Stains of Ganoderma tsugae. Edible and Medicinal Mushrooms, 2021; 29(03): 237-241.
    [28]
    Huang F H, Wang Q L. Interpretation of guidance on single dose toxicity study for pharmaceuticals. Chinese Journal of New Drugs, 2015; 24(4): 386-389+399.
    [29]
    Lin H, Jin L Z, Che C L, et al. Toxicological safety evaluation of sporoderm-broken spore powders of organic Ganoderma lucidum of Changbai Mountain. Journal of Food Safety & Quality, 2017; 8(2): 662-668.
    [30]
    Lin L, Liu K L, Lan Y T, et al. Acute and subacute toxicity evaluation of broken Ganoderma lucidum spore powder. Occupation and Health, 2022; 38(1): 23-26+31.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)  / Tables(1)

    Article Metrics

    Article views (53) PDF downloads(7) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return